Mass: 18.015 Da / Num. of mol.: 437 / Source method: isolated from a natural source / Formula: H2O
Has protein modification
Y
Nonpolymer details
THE COMPOUND USED FOR CO-CRYSTALLIZATION IS THE MAO B INHIBITOR PHENYLETHYLHYDRAZINE, WHICH IS ...THE COMPOUND USED FOR CO-CRYSTALLIZATION IS THE MAO B INHIBITOR PHENYLETHYLHYDRAZINE, WHICH IS MODIFIED BY THE PROTEIN PRODUCING A COMPOUND THAT CORRESPONDS TO PHENYLETHANE BOUND TO FAD.
-
Experimental details
-
Experiment
Experiment
Method: X-RAY DIFFRACTION / Number of used crystals: 1
-
Sample preparation
Crystal
Density Matthews: 2.7 Å3/Da / Density % sol: 54 % / Description: NONE
Crystal grow
Details: 12% PEG4000, 100MM ADA PH 6.5, 70MM LITHIUM SULPHATE
Method to determine structure: OTHER / Resolution: 2.3→15 Å / Cor.coef. Fo:Fc: 0.926 / Cor.coef. Fo:Fc free: 0.887 / SU B: 6.273 / SU ML: 0.156 / Cross valid method: THROUGHOUT / ESU R: 0.308 / ESU R Free: 0.229 / Stereochemistry target values: MAXIMUM LIKELIHOOD / Details: HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS.
Rfactor
Num. reflection
% reflection
Selection details
Rfree
0.246
1416
2.6 %
RANDOM
Rwork
0.2
-
-
-
obs
0.201
53412
97.5 %
-
Solvent computation
Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: BABINET MODEL WITH MASK